Patent application number | Description | Published |
20100217350 | Wireless Electrical Stimulating Device for Living Body - A wireless electrical stimulating device for living body comprises a light source unit for irradiating an optical signal; a light source control unit for controlling the optical signal irradiated from the light source unit; and an electrical stimulating unit for converting the optical signal received from the light source unit into an electrical signal to generate electrical stimulation. In the wireless electrical stimulating device for living body, the electrical stimulating unit comprises a battery for supplying current; an optical switch for detecting the optical signal irradiated from the light source unit to switch current supplied from the battery; and a stimulating electrode for providing the current switched by the optical switch to a living body. | 08-26-2010 |
20100241006 | APPARATUS FOR DETECTING BRAIN CONDITIONS - Disclosed embodiments relate to an apparatus for detecting brain conditions. The apparatus for detecting brain conditions may include: a layer which is located adjacent to the brain of a living body; a light source which is formed on the layer and irradiates light to the brain; and an optical sensor which is formed on the layer adjacent to the light source and detects the light scattered from the brain. Since detection is possible at a location relatively adjacent to the brain, the apparatus for detecting brain conditions may improve accuracy and reliability of detection. The apparatus for detecting brain conditions may be used to detect brain conditions such as cerebral oxygenation, cerebral blood volume, cerebral blood flow, etc. or to monitor brain activities, or to diagnose and/or localize the disease foci in case of neurovascular disease such as stroke including hemorrhage or bleeding, into or around the brain or brain tumors or epilepsy, etc. Since the apparatus for detecting brain conditions has a relatively flexible structure, damage to the brain tissue may be minimized. | 09-23-2010 |
20100249890 | PHOTOSTIMULATION APPARATUS - A photostimulation apparatus may include: a membrane for insertion into a living body; and at least one cell disposed on the membrane. Each cell may include a first light source for irradiating light to a photosensitive material in the living body. Further, a photostimulation apparatus may include: a membrane for insertion into a living body; and at least one first light source disposed on the membrane for irradiating light to a photosensitive material in the living body. Since the photostimulation apparatus is placed on the surface of cortex or dura, it may minimize damage of the brain tissue and may activate and/or inhibit a large area simultaneously using light. | 09-30-2010 |
20110100147 | Multi-Selective Micro Manipulator - Disclosed is a multi-selective micromanipulator capable of controlling the motion of a main mover using a single actuator to linearly move a plurality of submovers selectively. The multi-selective micromanipulator includes a main mover which moves linearly or rotationally with respect to an axis, a driving means which moves the main mover, a lever which is formed on the main mover, and a plurality of submovers which the lever contacts with selectively depending on the movement of the main mover, wherein a selected submover is linearly moved by the lever in a direction parallel to the axis direction. | 05-05-2011 |
20110190859 | POLYMER LINEAR ACTUATOR FOR MICRO ELECTRO MECHANICAL SYSTEM AND MICRO MANIPULATOR FOR MEASUREMENT DEVICE OF CRANIAL NERVE SIGNAL USING THE SAME - A polymer linear actuator for a micro electro mechanical system (MEMS) and a micro manipulator for a measurement device of cranial nerve signal using the same are provided. The polymer linear actuator has first and second bodies positioned spaced apart to a distance from each other, and one or more pairs of V-type moving units connecting the first and second bodies together, wherein the moving units in pair are opposed to each other to convert a rotation motion of the respective moving units into a linear motion, thereby causing the first and second bodies to move linearly. | 08-04-2011 |
20110319456 | BENZOARYLUREIDO COMPOUNDS, AND COMPOSITION FOR PREVENTION OR TREATMENT OF NEURODEGENERATIVE BRAIN DISEASE CONTAINING THE SAME - Novel benzoarylureido compounds and a use thereof for prevention and/or treatment of the neurodegenerative brain disease are provided. The neurodegenerative brain diseases may include Alzheimer's disease, dementia, Parkinson's disease, stroke, amyloidosis, Pick's disease, Lou Gehrig's disease, Huntington's disease, Creutzfeld-Jakob disease, and the like. | 12-29-2011 |
20120143074 | METHOD OF EVALUATING SUITABILITY FOR DRUG THERAPY FOR THE PREVENTION AND TREATMENT OF ANXIETY DISORDERS USING CHOLINERGIC TYPE II THETA RHYTHM - The present invention relates to a drug suitability assessment method for the prevention or treatment of anxiety disorders using the cholinergic type II theta rhythm, and, more specifically, to a method for detecting individuals suffering from anxiety disorders induced by an abnormality occurring in the cholinergic system using the type II theta rhythm profile which is based on findings that the cholinergic type II theta rhythm is lower in an animal anxiety model than in normal subjects and that cholinergic drug treatment induces the cholinergic type II theta rhythm to return to normal and reduces anxiety and thereby making it possible to determine if a subject can be appropriately administered with a cholinergic drug and to monitor progress after cholinergic drug treatment. | 06-07-2012 |
Patent application number | Description | Published |
20080201787 | Transgenic mouse whose genome comprises a homozygous disruption of its alpha1G gene, a method of preparing the same and use thereof - The disclosure concerns a method for resistance of epilepsy by suppressing the function of alpha 1G protein of T-type calcium channels, use of suppressor of alpha 1G protein for prevention or treatment for epilepsy, knockout mice resisting epilepsy by disrupting alpha 1G subunit of T-type calcium channel, and preparation method thereof. The α1G-knockout transgenic mouse can be used for investigating the relationship between diseases particularly neuropathy or psychopathy and the function of α1G T-type calcium channel via various behavioral tests since α1G subunit is mainly expression in central nervous system (CNS) and pheripheral nervous system (PNS). Further, the α1G-knockout transgenic mouse can be used for screening antileptic agents. | 08-21-2008 |
20090325979 | NOVEL IMIDAZOLYLALKYLCARBONYL DERIVATIVES AS CALCIUM CHANNEL MODULATORS AND PREPARATION METHOD THEREOF - Disclosed are novel imidazolylalkylcarbonyl derivatives useful as calcium channel modulators and a preparation method of the same. Also disclosed is a method for the treatment of diseases by administering the above compounds based on their inhibitory activity against calcium channel. | 12-31-2009 |
20100004286 | NOVEL ISOINDOLINONE DERIVATIVES HAVING INHIBITORY ACTIVITY AGAINST T-TYPE CALCIUM CHANNEL AND METHOD FOR PREPARATION THEREOF - Disclosed are isoindolinone derivatives, represented by Chemical Formula 1, having inhibitory activity against T-type calcium channels, pharmaceutically acceptable salts thereof, a preparation method thereof, and a pharmaceutical composition comprising the same as an active ingredient. | 01-07-2010 |
20100129348 | METHOD FOR DECREASING DEPRESSION BY INHIBITING THE ACTIVITY OF ALPHA 1B SUBUNIT OF N-TYPE CALCIUM CHANNEL - The present invention relates to the method for decreasing depression, more particularly to the method for decreasing depression by inhibiting the activity of alpha 1B subunit of N-type calcium channel. According to the present invention, inhibiting material of alpha 1B subunit of N-type calcium channel can effectively be used for the depression remedy. Also, anti-depression reagent can be screened using alpha 1B subunit of N-type calcium channel. | 05-27-2010 |
20100168759 | MICRO MANIPULATOR FOR ELECTRODE MOVEMENT IN NEURAL SIGNAL RECORDING - This disclosure relates to a micro manipulator having a simple structure and having high possibility of recording a biological signal of a neuron at a desired position by improving positioning resolution of an electrode disposed adjacent to a subject's brain neuron or an electrode holder attached with the electrode. The micro manipulator according to the disclosure includes: a motor which includes a shaft and a vibration portion; a mobile which is connected to the shaft so as to be movable along the shaft; and a frame which supports the motor, wherein an electrode is connected to the mobile in a direction parallel to a longitudinal direction of the shaft, and wherein when the mobile moves linearly in accordance with a vibration of the shaft due to the vibration portion, the electrode moves linearly. | 07-01-2010 |
20100217351 | APPARATUS FOR STIMULATING LIVING BODY - Disclosed is an apparatus for stimulating living body including a light source unit which irradiates an optical signal for generating an electrical signal; a photovoltaic cell unit which generates an electrical signal using a received optical signal; and an electrode unit which stimulates living body using the electrical signal, wherein the photovoltaic cell unit and the electrode unit are implanted in the living body. The apparatus for stimulating living body may be manufactured in a flexible form, so that it may extend the range of choice for site to be implanted for the apparatus. Further, the adoption of the photovoltaic cell unit avoids the need of surgical operation for the change of battery. | 08-26-2010 |
20110243917 | COMPOSITION FOR THE PREVENTION AND TREATMENT OF ABSENCE SEIZURES COMPRISING PKC AGONIST AS AN EFFECTIVE INGREDIENT - The present invention relates to a composition comprising PKC agonist as an active ingredient. More precisely, the present inventors confirmed that absence seizure specific SWD was reduced by administrating PKC agonist into an animal model. Therefore, the composition of the present invention comprising PKC agonist as an active ingredient can be effectively used for the prevention and treatment of absence seizure and for the production of health improving functional food. | 10-06-2011 |
20130131485 | TETRODE FOR MEASURING BIO-SIGNALS AND METHOD OF MANUFACTURING THE SAME - A tetrode for measuring bio-signals, the tetrode including four electrodes which extend in a lengthwise direction of the tetrode and are symmertrically arranged; and an insulation layer which surrounds the four electrodes to insulate the electrodes from each others. A method of manufacturing a tetrode for measuring bio-signals, the method including forming a first insulation layer; forming first and second electrodes on the first insulation layer and forming a second insulation layer on the first and second electrodes; and forming third and fourth electrodes on the second insulation layer and forming a third insulation layer on the third and fourth electrodes. | 05-23-2013 |